Glucosamine hydrochloride 500mg / Dimethyl sulfone 500mg tablets

Osteoarthritis is the most common musculoskeletal disorder, leading to reduced mobility and disability. Currently, in OA, basic therapy with slow-acting symptomatic drugs for the treatment of osteoarthritis (SYSADOA) is recommended, among which chondroitin sulfate (CS) and glucosamine hydrochloride (HS), as well as their combinations, have the most convincing evidence of effectiveness. The combined drugs of CS and HS include the drug ARTRA®. The purpose of this article was to provide a systematic review of the efficacy studies of the combination drug CS and HS (ARTRA®). Of the 20 publications on the study of the efficacy of ARTRA®, 6 articles with a total of 3683 patients met the inclusion criteria. In patients treated with ARTRA, both Visual Analogue Scale and Western Ontario and McMaster University Osteoarthritis Index pain relief was observed at all time points (3, 4, and 6 months). Functional capacity of patients also had positive dynamics in the intervention groups in all presented studies.

Abstract licence: CC BY-NC-SA 4.0

Chitin (β-(1-4)-poly-N-acetyl-D-glucosamine) is widely distributed in nature and is the second most abundant polysaccharide after cellulose. It is often converted to its more deacetylated derivative, chitosan. Previously, many reports have indicated the accelerating effects of chitin, chitosan, and its derivatives on wound healing. More recently, chemically modified or nano-fibrous chitin and chitosan have been developed, and their effects on wound healing have been evaluated. In this review, the studies on the wound-healing effects of chitin, chitosan, and its derivatives are summarized. Moreover, the development of adhesive-based chitin and chitosan are also described. The evidence indicates that chitin, chitosan, and its derivatives are beneficial for the wound healing process. More recently, it is also indicate that some nano-based materials from chitin and chitosan are beneficial than chitin and chitosan for wound healing. Clinical applications of nano-based chitin and chitosan are also expected.

Abstract licence: CC BY

This study aimed to evaluate the antioxidant and anti‐inflammatory effects of glucosamine nanoparticles (GNPs) grafted with gallic acid (GNPs‐g‐GA). Glucosamine hydrochloride (G‐HCl) was produced from shrimp shell, and then GNPs synthesized using ionic gelation method. GNPs‐g‐GA was prepared by coupling GNPs with GA via 1‐ethy‐3‐(3‐dimethylaminopropyl)‐carbodiimide (EDC) in combination with N‐hydroxysuccinimide (NHS) cross‐linking agents. The results indicated that the grafting of GA onto GNPs at different ratios increased the average size of the nanoparticles from 195.7 to 294.2 nm with various grafting degrees ranging from 73.3 to 146.4 mg GA/g GNPs‐g‐GA. The SEM images revealed the formation of spherical‐shaped GNPs‐g‐GA nanoparticles with approximate sizes ranging from 275.3 to 303.6 nm. The appearance of characteristic signals in the FT‐IR (C=C, C–O/C–C, and NH2) and 1H‐NMR (H‐2 and H‐6 at 6.95 ppm) spectra and the red shift in UV‐Vis spectrum provided further support of GNPs‐g‐GA successful synthesis. DPPH radical scavenging (from 20.0 to 70.4%) and ABTS radical scavenging (from 18.7 to 79.0%) activities and reducing power (nearly fivefold) sharply improved in GNPs‐g‐GA. Moreover, GNPs‐g‐GA was found nontoxic and drastically reduced the level of nitric oxide release and downregulated the synthesis of TNF‐α, IL‐1β, and IL‐6 in LPS‐induced RAW2647 murine macrophage cells through NF‐κB and MAPKs signaling pathways. Overall, these results suggested that the grafting of GNPs and GA is an effective strategy for the suppression of inflammation response and oxidation reaction in osteoarthritis.

Abstract licence: CC BY 4.0